These results demonstrate that zinc activates AKT and alleviates gut barrier dysfunction by inducing activation of the ZNG1‐METAP1‐PRMT5‐AKTSDMA pathway, and highlight that limiting histidine intake may have effective therapeutic potential for bowel diseases such as Crohn's disease and Ulcerative colitis. Here, PRMT5 is linked to Crohn disease.